This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
by Dennis Crouch The USPTO utility patent grant rate data reveals an interesting narrative of policy shifts and administrative changes over the past fifteen years. Continue reading this post on Patently-O.
Originally posted 2010-07-27 12:37:45. I took the patent law course, yes, but I wouldn’t presume to teach it. He’s been posting a series of items slowly walking through […] The post Patents explained appeared first on LIKELIHOOD OF CONFUSION. They’re explained by Arizona IP lawyer Tom Galvani.
In that litigation, the district court granted summary judgment of non-infringement in favor of Great Concepts, which the Eleventh Circuit affirmed on July 15, 2010. The Board then dismissed the cancellation action in December 2010 based on Tana’s failure to respond to its order to show cause.
Recently, amendments to the Implementing Regulations of the Chinese Patent Law were issued and will take effect from January 20, 2024. The Regulations align with the revisions made to the Patent Law in 2020 and provide further guidance.
New Patently-O Law Journal article by Colleen V. As the America Invents Act (AIA) turns 10, patent students across the country may be asking: if the law is already a decade old, why am I spending so much time learning pre-AIA law? Figure 1: Percentage of Patent Litigations Including a Pre-AIA Patent, by Year Litigation Initiated.
Recently, an interesting order was issued in Patent Application No. 202417006578 ( pdf ), by Vikas Verma, Assistant Controller of Patents & Designs, Patent Office (Chennai), in the context of a pre-grant opposition (PGO) against an application by Pharmazz Inc. back in 2010. Image from here.
Balaji of the Madras High Court (MHC) delivered two decisions that overturned the Controller’s rejection of patent applications, siding with the appellants in both cases. Bitter Pill to Swallow: Controller’s Decision Overturned for Kyrorin’s Patent Application The first one is Kyorin Pharmaceutical Co v. 5360/CHENP/2010).
Even amid increased attention to gender disparities in the legal profession, the percentage of first chair trial lawyers in patent cases who are women increased only slightly from 2010 to 2019 and remains at less than 10%, a new analysis has found.
Ironburg won a $4 million judgment regarding two patents (now on appeal) and the district court stayed the litigation regarding U.S. Patent Nos. Those two patents are the subject of this appeal. Valve submitted a printout of Burns and argues that it was a printed copy of an online review of a Scuf controller from 2010.
New Patently-O Law Journal article by Colleen V. As the America Invents Act (AIA) turns 10, patent students across the country may be asking: if the law is already a decade old, why am I spending so much time learning pre-AIA law? Figure 1: Percentage of Patent Litigations Including a Pre-AIA Patent, by Year Litigation Initiated.
In our new paper, The Truth About Design Patents , we debunk three widely held—but incorrect—views about U.S. design patents. Taken together, these myths paint a grim picture of design patents: Half of all design patent applications are rejected. Most asserted design patents are invalidated in litigation.
The following list ranks the top 25 firms with the most registered patent law professionals. All of these firms have 100+ patent attorneys/agents. I also include a note following the firm with some information about how the numbers have changed since 2010. Fish & Richardson (Steady). Qualcomm (Some growth).
Moderna recently sued Pfizer alleging patent infringement of three out of eight patents that cover its Covid 19 vaccine (Spikevax). The sheer size of sales and revenue coupled with patent monopolies and the immense potential of the mRNA technology, makes both these entities King-like – rich, supreme and sometimes hypocritical.
We recently came across two decisions by the Indian Patent Office (IPO) in which patent claim applications concerning two nicotine delivery devices were rejected on the ground of the same being affected by section 3(b) of the Indian Patents Act, 1970. Section 3(i) bars the patenting of treatment processes.
While there is a high prevalence of generic alternatives, the agrochemicals industry in India is observing an increase in the number of patent applications filed. Even outside of patents, the players in the pesticide industry have consistently been pushing for TRIPS+ protections such as extended data exclusivity (see here , here , and here ).
769 on December 21, 2023 to enact the Implementing Regulations of the Patent Law (Amended in 2023) (hereinafter referred to as “the Implementing Regulations (Amended in 2023)”) as of January 20, 2024. Fourteen years have passed since the last amendment of the Implementing Regulations released on January 9, 2010.
COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Patent no. ’127
INTRODUCTION To identify the role of public funded research in the pharmaceutical industry one has to first determine the problems faced by the public in accessing these inventions and the level of patenting activities in the public funded research institutions in the pharmaceutical sector.
Moderna and Pfizer battle’s over the inventive process of their respective mRNA COVID-19 vaccines revisit the negative associations of profit, monopolies, and optics in patent litigation. Moderna claimed that they had registered foundational mRNA patents between 2010 and 2016. This exposes some concerns about our patent laws.
Patent linkage is perhaps one of the most debatable aspects of patent regulation around the world. Various countries have often tried to explain different ambits of patent linkage following the situation prevailing. This way the authorities take the responsibility of a patent office to which they don’t have any expertise.
A world first – South Africa recently made headlines by granting a patent for ‘a food container based on fractal geometry’ to a non-human inventor, namely an artificial intelligence (AI) machine called DABUS. Each of these three jurisdictions found sufficient reasons in these formalities to reject DABUS’ patent applications.
The USPTO is seeking comments on “the state of patent eligibility jurisprudence” and how eligibility law impacts both innovation and investment-in-innovation. and (2) Is patent eligibility a question of law for the court or a question of fact for the jury? The deadline for submissions is October 15, 2021. Berkheimer, No.
On December 11, 2023, the State Council of the People’s Republic of China announced its decision to amend the Implementing Regulations of the Patent Law of the People’s Republic of China (the “2023 Regulations”), marking the first update in over 13 years since the last amendment in 2010. By: Sheppard Mullin Richter & Hampton LLP
In a precedential decision published Monday, the United States Court of Appeals for the Federal Circuit (CAFC) affirmed the Patent Trial and Appeal Board’s (PTAB) decision to invalidate a pharmaceutical patent owned by the University of Minnesota. Patent 8,815,830 as unpatentable.
This post delves into these cases and what I call the ‘glove doesn’t fit’ fallacy in patent law obviousness doctrine; it also provides a discussion of how written description continues to be a risk, even in inter partes review (IPR) proceedings. Continue reading this post on Patently-O.
WIPO highlighted that similar treaties are in place: the Patent Law Treaty of 2000 , the Trademark Law Treaty of 1994 and the Singapore Treaty on the Law of Trademarks of 2006. This is referred to as a proposed new ‘patent disclosure requirement’. plants, animals, and microorganisms), and knowledge systems.
New Patently-O Law Journal article by David Boundy , a partner at Potomac Law Group, PLLC. Mr. Boundy practices at the intersection of patent and administrative law, and consults with other firms on court and administrative agency proceedings, including PTAB trials and appeals. Prior Patently-O Patent L.J.
Smart contracts are often mentioned in blockchain-themed patent applications and recited in claims. 593, 611 (2010)). Without detailed explanations of “smart contract” set forth in the specification, patent prosecutors may find themselves in an uphill battle against the abstract idea finding. The Situation. Kappas , 561, U.S.
In 2010, Trading Technologies International, Inc. (“TT”) TT”) filed suit against IBG LLC and its subsidiary Interactive Brokers LLC for patent infringement. The four patents in question, U.S. Patent Nos. By: Sheppard Mullin Richter & Hampton LLP
Figure 1 shows the number of Federal Circuit opinions and Rule 36 summary affirmances by origin since 2010. The average rate at which the court affirmed-in-full district courts from 2010-2021 was 69% (indicated by the purple line); last year its affirmance rate in these appeals was 79%.
Almost two years after the 2021 amendments to the Patent Rules 2003, the Ministry of Commerce and Industry has proposed a fresh set of amendments which, if accepted, can change the Indian Patent landscape substantially. from Jindal Global Law School, Sonipat.]
Sander Gelsing, Canadian Patent and Trademark Trade Mark Lawyer, picks up on a doozy. Originally posted 2010-05-26 12:48:34. The post Talk about your business method patents! Republished by Blog Post Promoter. appeared first on LIKELIHOOD OF CONFUSION™.
Patents set themselves apart from other IP rights as inventions are often composed of multiple physical components or steps in a method, which does not necessarily have to exist or be performed at the same time and place. The traditional notion that patents are territorial rights is, however, under considerable stress.
I covered the recommendations of the Report which includes reforming Section 3(p) of the Patents Act to incentivize TK-based innovation, creating a proper documentation mechanism to prevent misappropriation of TK, and registration of traditional knowledge as GIs. of patents were generated by research teams consisting mostly of women.
The Patent Agent Examinations are due on January 07, 2024. Choudhary about a wonderful new initiative he’s put together online, Prepare for the Patent Agent Examination (PAEP), a free for all website for the aid and assistance of the participants appearing in the Patent Agent Exam. So best wishes to the Exam Takers!
593 (2010). Often, eligibility is the first substantive determination in patent litigation and it is typically decided either on a motion to dismiss (12(b)(6)) or motion on the pleadings (12(c)). In recent years, eligibility determinations have moved forward in the litigation context and become a true “threshold test.”
Canada’s patent portfolio is incommensurate with its enviable workforce and publicly funded research. Domestically, Canadian patent filings decreased by 3% annually and 7% in the last ten years. In 2019, Canadians contributed 12% of the patents filed in Canada, whereas Americans accounted for half.
And the other is whether the patent in question, titled pharmaceutical combinations of an Angiotensin Receptor Antagonist and an NEP Inhibitor (IN 414518), is a secondary patent to the recently expired Vymada patent (combination of Valsartan-Sacubitril). However, of these 8 claims, Natco alleged that Claim no.
The court in Ariad explained that a “a vague functional description” may be insufficient as it likely describes the unpatentable problem rather than a patentable solution. 2010) (en banc). I suggest that patent examiners are primarily focusing on Number 1, New Matter Written Description. Ariad Pharmaceuticals et al.
Design patents allow breweries to safeguard these elements of aesthetic distinction, securing exclusive rights to their innovative designs. Some examples of beer glasses design patents in the US: BEER GLASS US D954,504 S Inventors: Nicolas Brouillac Assignee: PEUGEOT SAVEURS Date of Patent: Jun. Date of Patent: May.
The USPTO implemented the Patent Prosecution Highway (PPH) back in May of 2010. For example, for FY22 (Oct 2021 – Sept 2022), in participating patent offices with at least 100 petitions filed, [1] the average pendency in days from petition to a First Action was 144 (roughly 4.8
I have been following the patent ownership lawsuit of Bio-Rad Laboratories, Inc. Some months later, after leaving and forming 10X, they completed the inventions and filed patent applications. International Trade Commission and 10X Genomics. The case is now pending on a petition for en banc rehearing before the Federal Circuit.
government by using fraudulently obtained patent rights prop up its drug prices. 280 (2010). In a case now pending before the Supreme Court, Silbersher argues that Valeant fraudulently obtained patents for its drug Apriso, allowing it to delay generic competition and charge inflated prices to the government. 3729 (a)(1)(A).
Since 2010—with the exception of outlier year 2016 (with 310 new filings!)—the the number of cases filed annually in US district courts asserting US design patents has remained fairly steady: between 236 (in 2019) and 293 (in 2017). 2021 was no different with 254 new design patent cases filed.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content